07:00 , Jun 22, 2009 |  BC Week In Review  |  Company News

Oscient infectious, metabolic news

In February, Oscient restructured its commercial operations, reduced headcount and retained Broadpoint Capital Inc. to advise on strategic options. At Dec. 31, 2008, Oscient had $17.2 million in cash and a 12-month operating loss of...
08:00 , Feb 16, 2009 |  BC Week In Review  |  Company News

Oscient infectious, metabolic news

Oscient will restructure its commercial operations, reduce headcount by 100 (32%) to 205 and will not fill 25 vacant positions to preserve capital. The majority of the cuts will be in sales. Oscient also retained...